NEVRO CORP. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-11-02: Form 8-K; Period of report 2022-11-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2022-09-09: Form 8-K; Period of report 2022-09-07; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2022-08-03: Form 8-K; Period of report 2022-08-03; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2022-08-01: Form 8-K; Period of report 2022-08-01; Description 8.01 Other Events; Details 8.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2022-11-02 | 8-K | 2022-11-02 | 2.02 Results of Operations and Financial Condition | 2.02 On November 2, 2022, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and nine months ended September 30, 2022. | nvro-20221102.htm |
| 2022-09-09 | 8-K | 2022-09-07 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 7, 2022, the Board of Directors of Nevro Corp (“Nevro” or the “Company”) promoted Richard B. Carter to Chief Accounting Officer of the Company, effective September 7, 2022. | nvro-20220907.htm |
| 2022-08-03 | 8-K | 2022-08-03 | 2.02 Results of Operations and Financial Condition | 2.02 On August 3, 2022, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and six months ended June 30, 2022. | nvro-20220803.htm |
| 2022-08-01 | 8-K | 2022-08-01 | 8.01 Other Events | 8.01 On August 1, 2022, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its agreement with Boston Scientific Corporation ("Boston Scientific") to settle their ongoing intellectual property litigations. | nvro-20220801.htm |
| 2022-05-31 | 8-K | 2022-05-26 | 5.07 Submission of Matters to a Vote of Security Holders | nvro-8k_20220526.htm | |
| 2022-05-04 | 8-K | 2022-05-04 | 2.02 Results of Operations and Financial Condition | 2.02 On May 4, 2022, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three months ended March 31, 2022. | nvro-8k_20220504.htm |
| 2022-02-23 | 8-K | 2022-02-23 | 2.02 Results of Operations and Financial Condition | 2.02 On February 23, 2022, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three months and full year ended December 31, 2021. | nvro-8k_20220223.htm |
| 2022-01-10 | 8-K | 2022-01-10 | 2.02 Results of Operations and Financial Condition | nvro-8k_20220110.htm |